BACKGROUND	To assess the safety of symptom-limited exercise testing in patients with New York Heart Association class II-IV heart failure symptoms due to left ventricular systolic dysfunction , we investigated the frequency of all-cause fatal and nonfatal major cardiovascular ( CV ) events among subjects enrolled in a prospective clinical trial ( HF-ACTION ) .\